7 medtech stories we missed this week: June 8, 2018
[Image from unsplash.com]From Royal Philips receiving FDA clearance to NeuroPace launching its epilepsy treatment device, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Philips’s Ingenia Elition 3.0T MR scanner Royal Philips announced in a June 5 press release that it has received FDA 510(k) clearance for its Ingenia Elition 3.0T MR solution and its two clinical applications Philips Compressed Sense and 3D APT. The products help clinicians perform exams up to 50% faster while increasing diagnostic confidence and improving patient experience. 2. Pentax to di...
Source: Mass Device - June 8, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Implants Neurological Neuromodulation/Neurostimulation Patient Monitoring Regulatory/Compliance branchpointtechnologies Cook Medica Source Type: news

Restech acquires Mederi Medical
Medtech developer Respiratory Technology Corp said today it acquired Mederi Therapeutics, and its Stretta catheter and Secca system, for an undisclosed amount. Houston-based Restech said that the addition of the Stretta catheter, designed to treat gastroesophageal reflux disease, and the Secca system, designed to treat bowel incontinence, are complimentary to its existing diagnostic devices. Mederi’s Stretta catheter system is designed to apply low-power radio frequency energy to remodel the lower esophageal sphincter to restore natural barrier function and reduce spontaneous regurgitation caused by transient relaxat...
Source: Mass Device - April 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Catheters Mergers & Acquisitions Mederi Therapeutics respiratorytechnologycorp Source Type: news

HeartStitch wins CE Mark for CoAp Pro mitral valve repair device
HeartStitch said today it won CE Mark approval in the European Union for its CoAp Pro device designed for mitral valve remodeling and repair. The Fountain Valley, Calif.-based company said its CoAp Pro device is designed to allow physicians to remodel mitral valve leaflets to re-establish proper coaptation. “I am especially pleased to see HeartStitch receive this approval, because it provides the ability to use suture to remodel the mitral valves rather than the need to place a prosthetic device in the leaflets. In my opinion it is a significant advancement to the treatment of mitral regurgitation. Personally, I hav...
Source: Mass Device - April 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Regulatory/Compliance HeartStitch Source Type: news

HeartStitch touts tricuspid repair feasibility cases
Structural heart focused medtech company HeartStitch said today that its HeartStitch Remo Pro suture technique was used in a world first procedure to repair the tricuspid valve of two patients as part of a feasibility trial of the technique and the supporting technology. The procedures were performed by Dr. Yuri Pya at Astana, Kazakhstan’s National Research Cardiac Surgery Center, the company said. Both patients in the trial required tricuspid heart valve repair to remodel the annulus of their tricuspid valve to treat tricuspid regurgitation. Patients in the feasibility test tolerated the procedure and have been dis...
Source: Mass Device - April 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials HeartStitch Source Type: news

The p85 isoform of the kinase S6K1 functions as a secreted oncoprotein to facilitate cell migration and tumor growth
We report that p85S6K1, the longest isoform of S6K (ribosomal protein S6 kinase), but not the shorter isoform p70S6K1 or p56S6K2, was secreted from cancer cells through its HIV TAT-like, N-terminal six-arginine motif. The exogenously produced p85S6K1 protein entered cultured transformed and nontransformed cells to promote or confer malignant behaviors, leading to increased cell growth and migration. When injected into mice, the p85S6K1 protein enhanced the growth of xenografted breast cancer cells and lung metastasis. Hence, our findings reveal a role for p85S6K1 as a secreted oncogenic kinase and provide a mechanism by wh...
Source: Signal Transduction Knowledge Environment - March 27, 2018 Category: Science Authors: Zhang, J., Guo, J., Qin, X., Wang, B., Zhang, L., Wang, Y., Gan, W., Pandofi, P. P., Chen, W., Wei, W. Tags: STKE Research Articles Source Type: news

Postcatalytic spliceosome structure reveals mechanism of 3'-splice site selection
Introns are removed from eukaryotic messenger RNA precursors by the spliceosome in two transesterification reactions—branching and exon ligation. The mechanism of 3'–splice site recognition during exon ligation has remained unclear. Here we present the 3.7-angstrom cryo–electron microscopy structure of the yeast P-complex spliceosome immediately after exon ligation. The 3'–splice site AG dinucleotide is recognized through non–Watson-Crick pairing with the 5' splice site and the branch-point adenosine. After the branching reaction, protein factors work together to remodel the spliceosome and st...
Source: ScienceNOW - December 7, 2017 Category: Science Authors: Wilkinson, M. E., Fica, S. M., Galej, W. P., Norman, C. M., Newman, A. J., Nagai, K. Tags: Biochemistry, Molecular Biology r-articles Source Type: news

Wichita contractor selected for remodel at Hutchinson hospital
The work is part of a larger facilities improvement project already heavily dependent on local contractors and a local architecture firm.
Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2017 Category: Biotechnology Authors: Josh Heck Source Type: news

Sullivan Centre owners lose millions to Ponzi scheme, place office remodel/retirement on hold
Michael and Christine Sullivan have been running their own plastic surgery business in north Columbus for 21 years. In their early 60s, the couple had plans for a major remodel of their office to bring more spa-like services into the fold and recently were preparing for semi-retirement. All that changed this spring and summer when they found out their money manger had wiped out their life savings.
Source: bizjournals.com Health Care:Biotechnology headlines - September 11, 2017 Category: Biotechnology Authors: Laura Newpoff Source Type: news

Bone stress injuries in the military: diagnosis, management, and prevention - DeFroda SF, Cameron KL, Posner M, Kriz PK, Owens BD.
Bone stress injuries occur when forces applied to a bone for an extended period exceed the ability of the bone to adequately remodel. These injuries, which range from stress reactions to nondisplaced and even displaced fractures, most often affect people w...
Source: SafetyLit - September 1, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Paying it forward: Care for son ’s craniosynostosis spurs mom to run marathon
Will Flanigan can’t stop giggling. Whether he’s teasing his older sister, Spencer, or charming his way out of trouble with his parents, this toddler “is always cracking himself — and us — up,” says his mother, Caroline. “We call him Will the Thrill.” On April 17, 2017, Will brought his good humor from his home in Dallas to the Boston Marathon finish line, where he joined his family in cheering on Caroline as she ran. But this wasn’t just any race. Caroline was running with Boston Children’s Hospital’s Miles for Miracles team for a very special reason: Almost exactly a year earlier, Will was a...
Source: Thrive, Children's Hospital Boston - May 12, 2017 Category: Pediatrics Authors: Jessica Cerretani Tags: Diseases & Conditions Our Patients’ Stories Boston Marathon Craniofacial Program craniosynostosis Dr. Mark Proctor Source Type: news

Impulse Dynamics raises $45m
Impulse Dynamics said today it closed a $45 million equity financing round to support its cardiac contractility modulation technology designed to treat chronic heart failure. The round was led by Goldstone Investment and was joined by several other international investment firms, the Stuttgart, Germany-based company said. “We believe that CCM addresses a significant unmet need in the Chronic Heart Failure treatment paradigm. We look forward to seeing Impulse realize its potential of helping millions of patients globally who currently can’t get symptom relief with existing device therapies,” Goldstone Inve...
Source: Mass Device - May 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Impulse Dynamics Source Type: news

Uncertain Fate Of Obamacare Causes Some Hospitals To Halt Projects, Hiring
(Reuters) - Uncertainty surrounding the Republican plan to replace Obamacare is forcing someU.S. hospitals to delay expansion plans, cut costs, or take on added risk to borrow money for capital investment projects, dealing an economic blow to these facilities and the towns they call home. Hospitals typically lay out multi-year operating plans that prioritize investments, such as new clinics, medical wings, technology or other projects that help draw in more patients and increase revenue. In addition to enhancing patient care, these projects are vital to the local economy as a driver of jobs ranging from construction and ma...
Source: Healthy Living - The Huffington Post - March 24, 2017 Category: Consumer Health News Source Type: news

Mederi touts meta-study of Stretta GERD treatment device
Data from a meta-analysis study of Mederi Therapeutics Stretta device released this week indicate that treatments with the device reduced heartburn and improved health-related quality of life scores for patients with gastroesophageal reflux disease. The company’s Stretta catheter system applies low-poet radio frequency energy to remodel the lower esophageal sphincter to restore natural barrier function and reduce spontaneous regurgitation caused by transient relaxations of the sphincter. In the study, researchers analyzed results from 28 studies of the Stretta system, including data from 2,468 unique Stretta patients. Re...
Source: Mass Device - February 27, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Otolaryngology Ear, Nose & Throat Mederi Therapeutics Inc. Source Type: news

' Smart ' bacteria remodel their genes to infect our intestines
Researchers have described how infectious bacteria can sense they ’re attached to our intestinal cells, and then remodel their expression of specific genes, including those involved in virulence and metabolism, to exploit our cells and colonize our gut.
Source: ScienceDaily Headlines - February 22, 2017 Category: Science Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10